[{"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "2 Bags", "code_info": "Compounded on 05/10/15, Discard After: 06/10/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Vancomycin HCl, Vancomycin 1500mg / D5W 265mL, Qty: 2 265 mL Bags, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1191-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0543-2017", "product_description": "SALICYLIC ACID SOLUTION in all strengths including  20%, 25%, 30%, and 40%,  SALICYCLIC  ACID 20%. 2.5%5-FU, SALICYCLIC ACID 20%,  5-FU 2.5% CREAM,  SALICYCLIC ACID 20%/5-FU 2.5% MEDICATION STICK,  Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Boothwyn", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65180", "recalling_firm": "Pentec Health", "address_1": "4 Creek Pkwy Ste A", "address_2": "N/A", "postal_code": "19061-3132", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dialysis Centers  Direct to patient", "recall_number": "D-587-2013", "product_description": "Proplete 52 - 59 KG (Intradialytic Parenteral Nutrition - dialysate solution with added amino acids), in a) 485mL bag and b) 490mL bag, Pentec Health Inc  4 Creek Parkway Suite A Boothwyn, PA  19061-3132", "product_quantity": "25 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.", "recall_initiation_date": "20130515", "center_classification_date": "20130606", "termination_date": "20141216", "report_date": "20130612", "code_info": "Compounding Date: 04/24/13, 04/25/13, 04/29/13 Discard after: 05/15/13, 05/16/13, 05/20/13"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0425-2020", "product_description": "Altaire Sterile Eye Wash, 118 mL (4 fl oz), Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-175-35", "product_quantity": "809,600 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17087 3/20   17088 3/20  17109 4/20   17110 4/20  17306 10/20   17307 10/20   17318 10/20   17323 10/20   18014 1/21   18045 2/21   18059 3/21   18063 3/21   18117 5/21   18134 5/21   18228 9/21   18261 10/21   19119 4/22   16207 8/19   16233 8/19   16250 9/19   16268 10/19   16301 11/19"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0253-2018", "product_description": "Medline CC Drawer 4 IV Circulation Pack, Contains Rx, Single Use Only, contains 2 Prep Pad PVPs. Packaged in USA for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "51 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: ACC010254A; Lots: 17HD4376; 17HD1709; 17HD1709", "more_code_info": ""}, {"status": "Terminated", "city": "Newtown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040786"], "brand_name": ["HYDROXYZINE HYDROCHLORIDE"], "generic_name": ["HYDROXYZINE HYDROCHLORIDE"], "manufacturer_name": ["KVK-Tech, Inc."], "product_ndc": ["10702-010", "10702-011", "10702-012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROXYZINE DIHYDROCHLORIDE"], "rxcui": ["995218", "995258", "995281"], "spl_id": ["eff46bea-a884-5878-e053-2a95a90ae664"], "spl_set_id": ["adc4cb73-77c6-48ff-aaf2-b3568d53de1f"], "package_ndc": ["10702-010-01", "10702-010-50", "10702-010-10", "10702-011-01", "10702-011-50", "10702-011-10", "10702-012-01", "10702-012-50", "10702-012-10"], "is_original_packager": [true], "upc": ["0310702012103"], "unii": ["76755771U3"]}, "product_type": "Drugs", "event_id": "67103", "recalling_firm": "KVK-Tech, Inc.", "address_1": "110 Terry Dr", "address_2": "Suite 200", "postal_code": "18940-3427", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico to wholesale distributors for sale to retail establishments.", "recall_number": "D-1031-2014", "product_description": "HydrOXYzine HCI Tablets USP 25 mg, 100, 500, and 1000 count bottles, Rx only.  Mfd by: KVK-TECH, INC, Newtown, PA 18940. 100 count NDC: 10702-011-01, 500 count NDC: 10702-011-50, 1000 count NDC: 10702-011-10.", "product_quantity": "249,096 bottles", "reason_for_recall": "Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.", "recall_initiation_date": "20131211", "center_classification_date": "20140122", "termination_date": "20150803", "report_date": "20140129", "code_info": "NDC: 10702-011-01: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot # 10789, exp.May-14;  lot #10790, exp. Jun-14; lot # 10791, exp. Jun-14: lot # 10792, exp. Aug-14; lot #10983, exp. Sep-14; lot #10984, exp.Sep-14; lot #10986, exp. Oct-14; lot #  11034, exp. Nov-14; lot #11035, exp. Dec-14; lot # 11036, exp. Dec-14; lot #11435, exp. Nov-15.    NDC: 10702-011-10: lot #10666, exp. Feb-14; lot #10733, exp. May-14;  lot #10789, exp. May-14; lot #10790, exp. Jun-14; lot #10791, exp. Jun-14; lot #10792,  exp. Aug-14; lot # 10983, exp. Sep-14; lot #10985, exp. Oct-14;  lot #11034, exp. Nov-14; lot #11038,  exp. Dec-14; lot #11435, exp. Nov-15.    NDC: 10702-011-50: lot #10666, exp. Feb-14;  lot #10733, exp. May-14; lot # 10789, exp. May-14; lot #10791, exp. Jun-14; lot# 10792, exp. Aug-14; lot # 10983, exp. Sep-14; lot # 10985, exp. Oct-14; lot # 10986, exp. Oct-14; lot # 11037, exp. Dec-14; lot #11435, exp. Nov-15.", "more_code_info": ""}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87283", "recalling_firm": "Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0303-2021", "product_description": "Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA", "product_quantity": "35 bottles", "reason_for_recall": "Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.", "recall_initiation_date": "20210127", "center_classification_date": "20210316", "report_date": "20210324", "code_info": "a) Lot #: 148969, Exp 7/31/2022, b) Lot #: 148791, Exp 7/31/2022, c) Lot #: 148991, Exp 7/31/2022"}, {"status": "Terminated", "city": "Decatur", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80310", "recalling_firm": "Akorn, Inc.", "address_1": "1222 W Grand Ave", "address_2": "", "postal_code": "62522-1412", "voluntary_mandated": "", "initial_firm_notification": "", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0916-2018", "product_description": "Acetylcysteine for Injection 6 g/30 mL (200 mg/mL). Rx Only. Manufactured by Akron Inc., Lake Forest, IL 60045. NDC 17478-660-30.", "product_quantity": "89,507 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20180622", "center_classification_date": "20180709", "termination_date": "20201106", "report_date": "20180718", "code_info": "Lots: 061496A, Exp. 06/2018; 111696A, Exp. 11/2018; 061947A, Exp. 06/2019; 091267A, Exp. 09/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1230-2019", "product_description": "Phenylephrine 0.8 mg/10 mL NS (0.08 mg/mL), (80 mcg/mL) syringe, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "1310 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: ED041911 Exp. 4/13/2019; ED051910 Exp. 4/14/2019; ED081910 Exp. 4/17/2019; ED091909 Exp. 4/18/2019; ED101910 Exp. 4/19/2019; ED111908 Exp. 4/20/2019"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020258"], "brand_name": ["APRACLONIDINE"], "generic_name": ["APRACLONIDINE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["61314-665"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["APRACLONIDINE HYDROCHLORIDE"], "rxcui": ["308345"], "spl_id": ["238af96f-2f89-9af4-e063-6394a90a9516"], "spl_set_id": ["04ad82af-e7ba-4f40-a120-be9d33cf0c7b"], "package_ndc": ["61314-665-05", "61314-665-10"], "is_original_packager": [true], "upc": ["0361314665058", "0361314665102"], "unii": ["D2VW67N38H"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1026-2022", "product_description": "Aparaclonidine Ophthalmic Solution 0.5% as base, 0.5%, 5 mL bottle, Rx only, MFG:Sandoz Pharma, NDC 61314-665-05", "product_quantity": "21 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Sarasota", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93847", "recalling_firm": "OMEZA LLC", "address_1": "1610 Northgate Blvd", "address_2": "", "postal_code": "34234-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US Nationwide", "recall_number": "D-0288-2024", "product_description": "Omeza Lidocaine Lavage pain relief oil 10*2mL VIALS", "product_quantity": "4390 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240119", "center_classification_date": "20240204", "termination_date": "20241017", "report_date": "20240214", "code_info": "Lots:  28622 2-1, Exp. 04/24/2024 286222-3, Exp. 1/25/2024 or 04/25/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-936-2013", "product_description": "B-COMPLEX/LIDO/B-12, 25MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "03202013@33", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ISOSORBIDE DINITRATE, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs:  SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD22845_10, EXP: 5/2/2014;  CALCITRIOL, Capsule, 0.5 mcg, NDC 63304024001, Pedigree: AD32757_10, EXP: 5/14/2014.", "address_2": "", "product_quantity": "384 Tablets", "code_info": "ISOSORBIDE DINITRATE, Tablet, 10 mg has the following codes:   Pedigree: AD25264_1, EXP: 5/3/2014;  Pedigree: AD32757_34, EXP: 5/14/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ISOSORBIDE DINITRATE, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781155601.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1000-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Libertyville", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M013"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["A-S Medication Solutions"], "product_ndc": ["50090-5313"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["198440"], "spl_id": ["91673a66-2b9e-47ee-bb4b-61ec914a6226"], "spl_set_id": ["061c91d5-5aa8-4556-a344-197b7e8a10b8"], "package_ndc": ["50090-5313-1", "50090-5313-2", "50090-5313-3", "50090-5313-4", "50090-5313-5"], "original_packager_product_ndc": ["0904-6730"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "94873", "recalling_firm": "A-S Medication Solutions LLC", "address_1": "2401 Commerce Dr", "address_2": "", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-0631-2024", "product_description": "Acetaminophen Extra Strength Tablets, 500 mg each, 100 count bottles, Packaged By: A-S Medication Solutions, Libertyville, IL 60048. NDC: 50090-5313-2", "product_quantity": "429 bottles", "reason_for_recall": "Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.", "recall_initiation_date": "20240621", "center_classification_date": "20240808", "termination_date": "20250507", "report_date": "20240814", "code_info": "Lot: 4138197; Exp 10/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-802-2015", "product_description": "Misoprostol 1% active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "27836 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0710-2019", "product_description": "Dr. King's SafeCare Rx Stye Freee..., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955012528, NDC 57955-0132-2", "product_quantity": "126 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 083115B Exp. 08/18; 061716A Exp. 06/19; 120516B Exp. 12/19; 010418F Exp. 01/20"}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0752-2016", "product_description": "Hydromorphone HCL 10 mg/ml, vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "5 vials", "code_info": "Lot # t12-30-2016@73, Exp 6/18/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 40/30/4 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/4mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0748-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0943-2022", "product_description": "Ondansetron Hydrochloride, 1 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0127-30.", "product_quantity": "911 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: B24015-22 BUD: 8/15/2022", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "94 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  01292015@32, 7/28/2015; 02232015@18, 5/20/2015; 02272015@31, 8/26/2015; 03092015@23, 9/5/2015; 03272015@32, 9/23/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone 200 mg Anastrazole 9 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1659-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1597-2019", "product_description": "Fungo Balm, 30 gram, Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx # 29083, Exp 05/21/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 700 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29083, Discard After 05/21/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1478-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "La Fayette", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89918", "recalling_firm": "Beak & Skiff Cider Mill, Inc.", "address_1": "4472 Cherry Valley Tpke", "address_2": "N/A", "postal_code": "13084-9729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in NY and sales were made via the internet.", "recall_number": "N/A", "product_description": "BEAK & SKIFF SANITIZER Alcohol Antiseptic 80%, Topical Solution Antiseptic Hand Rub Non-Sterile Solution, Packaged in a) 12OZ/355ML bottles, UPC 48558 94603 6 b) 5 Gallon/18,927ML pail  C)1 Gallon/3,785ML jug; d)4OZ/118ML spray top bottles; Produced By; Beak & Skiff Farms Apple Farms Inc. Lafayette, NY 13084.", "product_quantity": "396/12 oz. bottles, 11/5 gallon pails, 9/1 gallon jugs, 304/4 oz. bottles", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.", "recall_initiation_date": "20220404", "center_classification_date": "20220414", "termination_date": "20240701", "report_date": "20220420", "code_info": "Lot # 06090"}, {"status": "Terminated", "city": "Canton", "state": "SD", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "92457", "recalling_firm": "Jarman's Midwest Cleaning Systems, Inc.", "address_1": "824 N Grant St", "address_2": "N/A", "postal_code": "57013-1357", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0874-2023", "product_description": "SOFT HANDS Alcohol Antiseptic 80%, Topical Solution, HAND SANITIZER, NON-STERILE SOLUTION, cleanpro SUPPLY, 1 US gallon / 3785.41ml, plastic gallon bottle, MCS Midwest Cleaning Solutions, 404 Noid Rd., Canton, SD 57013.", "product_quantity": "7303 gallons", "reason_for_recall": "Chemical Contamination: FDA testing found Presence of methanol", "recall_initiation_date": "20230327", "center_classification_date": "20230614", "termination_date": "20250612", "report_date": "20230621", "code_info": "All product labelled with Date of Manufacture (DOM): DOM 26MAR2020; DOM 01APR2020;                        DOM 02APR2020; DOM 04APR2020; DOM 27APR2020; DOM 04MAY2020; DOM 07MAY2020; DOM 13MAY2020; DOM 04AUG2020."}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76819", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0702-2017", "product_description": "Olanzapine Tablets, 20 mg, packaged in a) 30-count bottles (NDC 62756-556-83), b) 100-count bottles (NDC 62756-556-88), and c) 1000-count bottles (NDC 62756-556-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India.", "product_quantity": "14,784 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).", "recall_initiation_date": "20170322", "center_classification_date": "20170510", "termination_date": "20180711", "report_date": "20170517", "code_info": "Lot #: a) JKR5759A, Exp 04/18; b) JKP0943A, Exp 04/17, JKR5520A, Exp 04/18; c) JKP0988A, Exp 04/17"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1030-2015", "product_description": "Nitroglycerin 0.2% Compd Cream, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2300", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Ondansetron 2mg/mL, 2 mL fill in a 3 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0957-69", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1334-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69798", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico,  Italy, Netherland, Spain", "recall_number": "D-0303-2015", "product_description": "Meropenem I.V. 1 g  is supplied in 30 mL injection vials, RX only. Manufactured by Hospira Healthcare India Pvt. Ltd Tamil Nadu, India for Hospira, Inc. 275 N. Field Drive, Lake Forest, IL 60045. NDC 0409-3506-01", "product_quantity": "261,706 vials", "reason_for_recall": "Defective Container: Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of sterility.", "recall_initiation_date": "20141024", "center_classification_date": "20141218", "termination_date": "20161215", "report_date": "20141224", "code_info": "Lot #:  609E014, Exp 1/2016; 609E015, Exp 1J/2016; 609E016, Exp 1/2016; 609E017, Exp 1/2016; 609E018, Exp 1/2016; 609E019, Exp 1/2016; 601E025,  Exp 1/2016; 601E027, Exp 1/2016; 601E028A, Exp 1/2016; 601E028B, Exp 1/2016; 601E028C,  Exp 1/2016"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA213238"], "brand_name": ["GLYCOPYRROLATE"], "generic_name": ["GLYCOPYRROLATE"], "manufacturer_name": ["Accord Healthcare, Inc.,"], "product_ndc": ["16729-471", "16729-472", "16729-473", "16729-474"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["GLYCOPYRROLATE"], "rxcui": ["238212", "1731582", "1731590"], "spl_id": ["415de5a5-d773-4816-e063-6294a90a6853"], "spl_set_id": ["871797f0-697a-4a29-a37b-d06219e8f266"], "package_ndc": ["16729-471-08", "16729-472-08", "16729-473-03", "16729-474-03", "16729-474-05", "16729-472-30"], "is_original_packager": [true], "upc": ["0316729474054", "0316729472302", "0316729473316", "0316729471633"], "unii": ["V92SO9WP2I"]}, "product_type": "Drugs", "event_id": "87233", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0250-2021", "product_description": "Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703, USA.  Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India NDC 16729-472-08 (Vial NDC 16729-472-30)", "product_quantity": "502 cartons", "reason_for_recall": "Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials", "recall_initiation_date": "20210128", "center_classification_date": "20210208", "termination_date": "20220208", "report_date": "20210217", "code_info": "Lot: M2013645 Exp. Aug. 2022"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0818-2019", "product_description": "Dr. King's SafeCare Rx Immature, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955229025, NDC 57955-2291-2", "product_quantity": "20 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 060716J Exp. 06/19"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:  0397741    0402847    0396295      0394438", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CLINDAMYCIN OPHTHALMIC (PF) 20MG/ML (2MG/0.1ML) SOLUTION\t2 ML;  CLINDAMYCIN PHOSPHATE OPHTHALMIC, INTRAVITREAL (P.F.) 1MG/0.1ML INJECTABLE 0.2 ML; CLINDAMYCIN PHOSPHATE SDPF- (0.1ML SYRINGE,30G,1/2\") 1MG/0.1ML INJECTABLE\t0.1 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1486-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103172"], "brand_name": ["CATHFLO ACTIVASE"], "generic_name": ["ALTEPLASE"], "manufacturer_name": ["Genentech, Inc."], "product_ndc": ["50242-041"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALTEPLASE"], "spl_id": ["5a8d3873-0072-421b-b244-e1801c097703"], "spl_set_id": ["91ecdef2-95ff-42dd-a31c-c8a09cab3ad9"], "package_ndc": ["50242-041-64", "50242-041-10"], "is_original_packager": [true], "unii": ["1RXS4UE564"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0476-2021", "product_description": "cathflo activase (ALTEPLASE) 2 mg Rx Only NDC 50242-041-64 Genentech", "product_quantity": "1473 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3410425"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0103-2020", "product_description": "SUCCinylcholine Chloride (PF), 100 mg / 5 mL (20 mg/mL), 5 mL Fill in a 6 mL Single Dose Syringe, For IV Use-Injection, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678418", "product_quantity": "7905 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73035", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "N/A", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0659-2016", "product_description": "Candesartan Cilexetil Tablets, 16 mg, a) 30 count (NDC 00781-5938-31) and b) 90 count (NDC 00781-5938-92) bottles, Rx Only, Manufactured by Mylan Laboratories Limited Hyderabad 500 034, India for Sandoz Inc. Princeton, NJ 08540", "product_quantity": "277,267 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; 9 month stability timepoint", "recall_initiation_date": "20151231", "center_classification_date": "20160211", "termination_date": "20170412", "report_date": "20160217", "code_info": "a)   3022288 12/2015  3025988 03/2016  3025989 04/2016  3030459 08/2016  3030460 08/2016  3032087 10/2016  3032088 10/2016  3034506 12/2016  3035952 01/2017  3035953 01/2017    b)   3022287 12/2015  3025990 04/2016  3030458 08/2016  3032086 09/2016  3035954 01/2017", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["WALGREENS SODIUM CHLORIDE OPHTHALMIC 5 PERCENT HYPERTONICITY EYE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Walgreen Company"], "product_ndc": ["0363-7500"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1298435"], "spl_id": ["2a930d08-8dfc-e567-e063-6294a90abda6"], "spl_set_id": ["bda3b9db-5fc4-408c-a5ae-d1eeb3ee308d"], "package_ndc": ["0363-7500-50"], "is_original_packager": [true], "upc": ["0311917214184"], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0361-2020", "product_description": "Walgreens Sodium Chloride Ophthalmic Ointment, 5% Hypertonicity Eye Ointment Sterile, Net Wt. 0.125 oz (3.5 g), Distributed by Walgreen Co. 200 Wilmot Road Deerfield, IL 60015, NDC 0363-7500-50", "product_quantity": "30240 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: TCI , Exp 03/21"}, {"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217455"], "brand_name": ["REGADENOSON"], "generic_name": ["REGADENOSON"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-364"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["REGADENOSON"], "spl_id": ["9f2129bf-2527-42da-b07a-f20cac3246de"], "spl_set_id": ["a81d66a7-b714-439e-ad7b-c7caf9d6f3b8"], "package_ndc": ["36000-364-01"], "is_original_packager": [true], "upc": ["0336000364010"], "nui": ["N0000178375", "N0000175788"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "unii": ["2XLN4Y044H"]}, "product_type": "Drugs", "event_id": "95664", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0039-2025", "product_description": "Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015.  NDC: 36000-364-01", "product_quantity": "60,594 units", "reason_for_recall": "Labeling: Missing Label", "recall_initiation_date": "20241030", "center_classification_date": "20241106", "report_date": "20241113", "code_info": "Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1409-2016", "product_description": "20 mcg/mL HYDROmorphone HCl and 0.06% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 55 mL in 60 mL Monoject Syringe, Service Code 2T6620, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-620-12", "product_quantity": "435 Monoject Syringes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2K8157 , Lot Number 160420116M , Exp. Date 5/12/2016 ;  Service Code 2K8157 , Lot Number 160540135M , Exp. Date 5/24/2016 ;  Service Code 2K8157 , Lot Number 160630121M , Exp. Date 6/2/2016 ;  Service Code 2K8157 , Lot Number 160730218M , Exp. Date 6/12/2016 ;  Service Code 2K8157 , Lot Number 160760126M , Exp. Date 6/14/2016 ;  Service Code 2K8157 , Lot Number 160770152M , Exp. Date 6/16/2016 ;  Service Code 2K8157 , Lot Number 160810169M , Exp. Date 6/20/2016 ;  Service Code 2K8157 , Lot Number 160840206M , Exp. Date 6/23/2016 ;  Service Code 2K8157 , Lot Number 160940210M , Exp. Date 7/3/2016 ;  Service Code 2T6620 , Lot Number 160900133M , Exp. Date 5/6/2016 ;", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1452-2022", "product_description": "READY IN CASE CTRZNE ALRGY ALL DY TBLT 5 CT SKU 900448   ZYRTEC CHILDRENS GRAPE 4 FL OZ SKU 999368  GOOD SENSE ALLERGY CETIRIZINE 10 MG TABLET 14 CT SKU 916897 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 900448; 999368; 916897", "more_code_info": ""}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "2 50 mL vials", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "DMSO 50% Sterile Bladder Irrigation Solution Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-288-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0455-2024", "product_description": "SILVERBACK XXX POWER MALE ENHANCEMENT, 2 fl. oz., UPC 8 700470 032762", "product_quantity": "7 pieces", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "North York", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["ANDA065040"], "brand_name": ["CYCLOSPORINE"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0133", "60505-0134"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["197553", "328160"], "spl_id": ["aa39e91b-f23e-69c8-e400-1f896c77b8e2"], "spl_set_id": ["bfca7088-fe93-abb9-3ec3-e6f5710a69c6"], "package_ndc": ["60505-0133-0", "60505-0133-2", "60505-0133-1", "60505-0134-0", "60505-0134-2", "60505-0134-1", "3605050134"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"], "upc": ["360505013401"]}, "product_type": "Drugs", "event_id": "76402", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Dr", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide", "recall_number": "D-0475-2017", "product_description": "CycloSPORINE Capsules, USP, 100 mg, 30 count bottle, Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, Manufactured for Apotex Corp., Weston, FL --- NDC 60505-0134-0", "product_quantity": "19,584 bottles", "reason_for_recall": "Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities.", "recall_initiation_date": "20170203", "center_classification_date": "20170223", "termination_date": "20220615", "report_date": "20170301", "code_info": "Lot MJ9837, Exp 07/2017.  NDC 60505-0134-0, UPC 360505013401"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0546-2022", "product_description": "Coated Phenylephrine HCl 5mg Tablet (Phenylephrine HCl 5mg ) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-338-00", "product_quantity": "7,983,360 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: M338  Bulk Lots: 19A070, 19B080, 19J043"}, {"status": "Terminated", "city": "Newark", "state": "DE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88617", "recalling_firm": "DuPont Nutrition USA, Inc", "address_1": "1301 Ogletown Rd", "address_2": "", "postal_code": "19711-5419", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one account that may have used it as a component in finished drug formulations, and further distributed Nationwide in the USA.", "recall_number": "D-0830-2021", "product_description": "Avicel RC-591 NF (MCC/Carboxymethylcellulose Sodium) NF, bulk powder, 80.0 KG drum, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711", "product_quantity": "80 kg", "reason_for_recall": "Microbial Contamination of Non-Sterile Product: Out-of-specification results obtained for total aerobic microbial count (TAMC).", "recall_initiation_date": "20210827", "center_classification_date": "20210923", "termination_date": "20220311", "report_date": "20210929", "code_info": "Lot # 2173766940", "more_code_info": ""}, {"status": "Completed", "city": "North York", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83871", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0317-2020", "product_description": "Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg Cool Mint Acid Reducer 24 Tablets Sugar Free NDC 11822-6107-4 Distributed By: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011", "product_quantity": "31,968 bottles", "reason_for_recall": "GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).", "recall_initiation_date": "20190924", "center_classification_date": "20191112", "report_date": "20191120", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86022", "recalling_firm": "4e Brands North America, Llc", "address_1": "17806 Ih-10 Ste 300", "address_2": "N/A", "postal_code": "78257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0030-2021", "product_description": "blumen ADVANCED INSTANT HAND SANITIZER Clear ETHYL ALCOHOL 70% natural boost with tea tree oil (70% ethyl alcohol), 33.8 fl oz / 1 L bottle, Distributed in USA and Canada by: 4e Brands 4e Brands Northamerica LLC. 17806 IH-10W, Suite 300, San Antonio, Texas, 78257. Made in Mexico. UPC 8 14266 02374 7", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination and Subpotent Drug: Product tested to contain methanol as well as below the labeled claim for ethanol content.", "recall_initiation_date": "20200711", "center_classification_date": "20201007", "termination_date": "20240226", "report_date": "20201007", "code_info": "Lot #: 2221, Exp 04/09/23; 2252, Exp 04/12/23"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203536"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-360", "59746-361", "59746-362", "59746-363"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["9c828bee-09d3-4021-99e7-e5fd3e83741c"], "spl_set_id": ["9402b022-5809-4251-dfef-54f6ef5723fe"], "package_ndc": ["59746-360-30", "59746-360-90", "59746-360-05", "59746-360-03", "59746-361-30", "59746-361-90", "59746-361-05", "59746-361-03", "59746-362-30", "59746-362-90", "59746-362-05", "59746-362-03", "59746-363-30", "59746-363-90", "59746-363-67", "59746-363-32"], "is_original_packager": [true], "upc": ["0359746363321", "0359746363307", "0359746361037", "0359746362034", "0359746360306", "0359746360030", "0359746361303", "0359746362300"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "80836", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States to wholesalers and retailers.", "recall_number": "D-1105-2018", "product_description": "Valsartan Tablets USP, 160 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-362-90", "product_quantity": "18,947 bottles", "reason_for_recall": "Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.", "recall_initiation_date": "20180814", "center_classification_date": "20180817", "termination_date": "20200108", "report_date": "20180829", "code_info": "Lot #: VR317040A, VR317041A, VR317042A, VR317043A, Exp. 08/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0507-2018", "product_description": "Lidocaine USP for prescription compounding, packaged in a) 25g (NDC 58597-8019-4); b) 100g (NDC 58597-8019-6); c) 500g (NDC 58597-8019-7); d) 1000  (NDC 58597-8019-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "74000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lots #: a) 110215-2, Exp. 09/30/2020; b) 110215-1, Exp. 09/30/2020; 082516-1, Exp. 05/31/2021; c) 110215-1, Exp. 09/30/2020; 082516-1, Exp. 05/31/2021;   d) 110215-1, Exp. 09/30/2020; 082516-1, Exp. 05/31/2021."}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1101-2017", "product_description": "Make Up Transparent pastel (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03210, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 032104.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 130917, Exp 09/13/2017; 310318, Exp 03/31/2018; 270718, Exp 07/27/2018; 081118, Exp 11/08/2018."}, {"country": "United States", "city": "Hurst", "address_1": "122 Grapevine Hwy", "reason_for_recall": "Labeling Not Elsewhere Classified: Misbranding.", "address_2": "", "product_quantity": "6580 capsules", "code_info": "Lots: 03272018@10 Exp. 09/11/2018; 03282018@8 Exp. 09/24/2018; 03282018@18 Exp. 09/24/2018; 04232018@3 Exp. 09/24/2018; 05302018@4 Exp. 10/22/2018; 06072018@6 Exp. 10/22/2018; 06212018@1 Exp. 10/22/2018; 06252018@7 Exp. 10/22/2018; 07192018@8 Exp. 10/22/2018; 07192018@10 Exp. 01/15/2019; 08282018@6 Exp. 2/23/2019; 08282018@7 Exp. 2/23/2019; 09142018@1 Exp. 02/23/2018; 09182018@10 Exp. 2/23/2019", "center_classification_date": "20181114", "distribution_pattern": "Distributed in California", "state": "TX", "product_description": "Progesterone SR 100 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054 817-282-9376. NDC 99999-0104-55", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Right Value Drug Stores, Inc.", "recall_number": "D-0240-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81198", "termination_date": "20201013", "more_code_info": "", "recall_initiation_date": "20180925", "postal_code": "76054-2406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["ROMPE PECHO"], "generic_name": ["GUAIFENESIN"], "manufacturer_name": ["Efficient Laboratories Inc"], "product_ndc": ["58593-829"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["GUAIFENESIN"], "rxcui": ["310604", "1112205"], "spl_id": ["26e4f72a-b911-8dc6-e063-6394a90a4326"], "spl_set_id": ["89ea23a5-0da7-407e-83d9-77a0b562f3af"], "package_ndc": ["58593-829-06", "58593-829-04"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["495W7451VQ"]}, "product_type": "Drugs", "event_id": "89205", "recalling_firm": "Efficient Laboratories, Inc.", "address_1": "7715 NW 64th St", "address_2": "N/A", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0292-2022", "product_description": "Rompe Pecho Ex Expectorant,  packaged in a) 4 Fl. Oz. (118 mL) bottles NDC 58593-829-04 and b) 6 Fl. Oz. (178 mL) bottles NDC 58593-829-06, Distributed by Efficient Laboratories, Inc. Miami, FL 33166", "product_quantity": "a) 7,800 bottles; b) 16,417 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20210824", "center_classification_date": "20211222", "termination_date": "20221208", "report_date": "20211229", "code_info": "Lot #: a) 19H20 Exp. August 2022; 19A418 Exp. January 2022; 19E411 Exp. May 2022; b) 19H20 Exp. August 2022; 19J98 Exp. September 2022; 19A418 Exp. January 2022; 19E411 Exp. May 2022"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1066-2018", "product_description": "Ropivacaine HCl 2 mg/mL 750 mL. Rx Only. Packaged in a ON-Q Pump. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "3 750-ml ON-Q Pump", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lot: 59103:42 Use By: 05/25/2018"}, {"country": "United States", "city": "Cleveland", "address_1": "913 N Davis Ave", "reason_for_recall": "Subpotent", "address_2": "", "product_quantity": "7,711 syringes", "code_info": "Service Code 2K2466 and 2K2470    183320004S, 183330008S, 183340002S, 183340003S, 183300004S, 183310007S, 183370041S, 183310043S, 183370042S, 183320003S, 183380007S, 183250013S, 183250014S, 183320005S, 183330009S, 183370007S, 183390044S, 183400006S, 183410003S.", "center_classification_date": "20190114", "distribution_pattern": "Product was distributed throughout the United States.", "state": "MS", "product_description": "0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478.", "report_date": "20190116", "classification": "Class II", "openfda": {}, "recalling_firm": "PharMEDium Services, LLC.", "recall_number": "D-0374-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81895", "termination_date": "20200507", "more_code_info": "", "recall_initiation_date": "20190102", "postal_code": "38732-2106", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "7 ml", "code_info": "All lots distributed between November 2014 and May 2015;    01052015@48, 7/4/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix MEDIUM (15/0.5/5) (MFG)  Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1791-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-946-2013", "product_description": "CYANOCOBALAMIN 1000 MCG/ML INJ SOLN, all presentations,  FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "01092013@12, 02132013@17, 03122013@21, 04122013@33, 05132013@17  05282013@26, 06052013@33, 06252013@4, 06272013@2, 07152013@41", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1403-2022", "product_description": "MY CHOICE LEVONORGESTREL TABLET distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 998211", "more_code_info": ""}, {"country": "United States", "city": "Lexington", "address_1": "300 Shire Way", "reason_for_recall": "Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing", "address_2": "", "product_quantity": "15,075", "code_info": "06628462, exp 5/31/2020  06651000, exp 9/30/2020  06661659, exp 6/30/2020   07110125, 07301073, exp 10/31/2020  07200435, 7/31/2020  07482211, exp 12/31/2020  07630714, exp 3/31/2021  NX170002DA, exp 12/31/2019  NX17004DA, exp 3/31/2020  NX17007DA, NX17007DB, NX17008DA exp 4/30/2020 NX17010DA, NX17012DA, exp 6/30/2020", "center_classification_date": "20191001", "distribution_pattern": "Product was distributed throughout the United States.", "state": "MA", "product_description": "Natpara (parathyroid hormone) for Injection, 75 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA  NDC 68875-0204-02", "report_date": "20191002", "classification": "Class I", "openfda": {}, "recalling_firm": "Shire Human Genetic Therapies, Inc.", "recall_number": "D-0037-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "83792", "termination_date": "20210323", "more_code_info": "", "recall_initiation_date": "20190912", "postal_code": "02421-2101", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-419", "60687-430", "60687-441", "60687-452", "60687-463"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["19336340-ad22-62b7-e063-6294a90affed"], "spl_set_id": ["d43718e5-66d7-44f9-9fc8-80d38d3e41ce"], "package_ndc": ["60687-419-11", "60687-419-01", "60687-430-11", "60687-430-01", "60687-430-65", "60687-441-11", "60687-441-01", "60687-452-11", "60687-452-01", "60687-463-11", "60687-463-01"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97533", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0647-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10) blisterpacks, NDC: 60687-430-01, (Individual Dose NDC: 60687-430-11), Rx Only,  Distributed by: American Health Packaging, Columbus, Ohio 43217.", "product_quantity": "2,708 cartons", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250827", "center_classification_date": "20250915", "report_date": "20250924", "code_info": "Lot:  a)1020919, 1021133, Exp 09/30/2026; 1021447, Exp 10/31/2026; 1021741, 1022202, Exp 11/30/2026; 1022474, Exp 12/31/2026  Lot: b) 1020460, exp 08/31/2026; 1022417, exp 12/31/2026"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1540-2019", "product_description": "DOTS SCENTED ANTIBACTERIAL HAND GEL STRAWBRRY (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "3852", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181023, Exp 10/22/2020"}, {"country": "United States", "city": "Telford", "address_1": "306 Keystone Dr", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product is being manufactured and distributed without a NDC number", "address_2": "Unit B", "product_quantity": "20,369 bottles", "code_info": "G12069 July 2014  H12087 August 2014  H12089 August 2014  L12161 December 2014  D13076 April 2015  G13120 July 2015  I13145 September 2015  J13165 October 2015  J13166 October 2015", "center_classification_date": "20140715", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Hemo-Stat Solution, Aluminum chloride 25%, in 37.2 g glass bottles, distributed by Benco Dental, Pittston, PA; Also distributed by Henry Shein, Melville, NY; and Hemoban distributed by iSmile Dental Products, Sacramento, CA", "report_date": "20140723", "classification": "Class II", "openfda": {}, "recalling_firm": "Axcentria Pharmaceuticals, LLC", "recall_number": "D-1434-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68481", "termination_date": "20161128", "recall_initiation_date": "20140505", "postal_code": "18969", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091650"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-121", "55111-122", "55111-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617310", "617311", "617312"], "spl_id": ["36e09eff-3948-2638-b633-d5ec2bc03d2a"], "spl_set_id": ["901550e6-22be-68c9-eb86-f85a9c9dd998"], "package_ndc": ["55111-121-30", "55111-121-60", "55111-121-90", "55111-121-05", "55111-121-10", "55111-122-30", "55111-122-60", "55111-122-90", "55111-122-05", "55111-122-10", "55111-123-30", "55111-123-60", "55111-123-90", "55111-123-05", "55111-123-10"], "is_original_packager": [true], "upc": ["0355111123903"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "88041", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0629-2021", "product_description": "Atorvastatin Calcium Tablets, USP 10 mg, 500-count bottles, Rx Only, Dr. Reddy's Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, 500-090 India, NDC 55111-121-05.", "product_quantity": "5984 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities", "recall_initiation_date": "20210604", "center_classification_date": "20210611", "termination_date": "20230216", "report_date": "20210623", "code_info": "Lot #: C905064, C905065, Exp. Date 07/2021", "more_code_info": ""}, {"country": "United States", "city": "Peapack", "address_1": "100 North Route 206", "reason_for_recall": "Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.", "address_2": "", "product_quantity": "9,666 units", "code_info": "Lot #: 03216025A, Exp.01/18.", "center_classification_date": "20170322", "distribution_pattern": "Nationwide within US", "state": "NJ", "product_description": "Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 900 mg/180 mL (25mg/5mL), Rx Only, Distributed by: NextWave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc, New York, NY 10017  Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852 (NDC 24478-190-30).", "report_date": "20170329", "classification": "Class III", "openfda": {}, "recalling_firm": "Pfizer Inc", "recall_number": "D-0609-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76663", "termination_date": "20190531", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "07977", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-306-2016", "product_description": "HCG 1000 Units/mL SUB-Q Injection, packaged in a)1.5 mL, b) 2 mL, c) 2.4 mL, d) 4 mL, e) 6 mL, f) 7.5 mL, g) 8 mL, and h) 9 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "49 vials", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 080415, Exp 09/04/2015; 080515, Exp 09/05/2015; 080615, Exp 09/06/2015; 080715, Exp 09/07/2015; 081015, Exp 09/10/2015; 081115, Exp 09/11/2015; 081215, Exp 09/12/2015; 081315, Exp 09/13/2015; 081415, Exp 09/14/2015; 1702-081715, Exp 09/17/2015; 1702-081815, Exp 09/18/2015; and 1702-081915, Exp 09/19/2015"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0781-2019", "product_description": "Dr. King's SafeCare Rx Good Mood Enhancer, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955208020, NDC 57955-2080-2", "product_quantity": "693 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 050317A Exp. 05/20; 072815S Exp. 07/18; 031016F Exp. 03/19; 071116G Exp. 07/19"}, {"status": "Terminated", "city": "Pithampur, District Dhar", "state": "N/A", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA078171"], "brand_name": ["LEVALBUTEROL INHALATION"], "generic_name": ["LEVALBUTEROL INHALATION 1.25MG/3ML"], "manufacturer_name": ["Dr. Reddys Laboratories, Inc."], "product_ndc": ["43598-409", "43598-412", "43598-410"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["LEVALBUTEROL"], "rxcui": ["242754", "311286", "349590"], "spl_id": ["8434771a-e4b6-e76a-1593-be9a47126006"], "spl_set_id": ["163dfa7c-aad3-4290-9fe9-d9592b0ba317"], "package_ndc": ["43598-412-05", "43598-412-25", "43598-410-05", "43598-410-25", "43598-409-05", "43598-409-25"], "is_original_packager": [true], "upc": ["0343598410258"], "nui": ["N0000009922", "N0000175779"], "pharm_class_moa": ["Adrenergic beta2-Agonists [MoA]"], "pharm_class_epc": ["beta2-Adrenergic Agonist [EPC]"], "unii": ["EDN2NBH5SS"]}, "product_type": "Drugs", "event_id": "71133", "recalling_firm": "Cipla Limited", "address_1": "Plot No. 9 &amp; 10 Pharma Zone Phase II", "address_2": "Section III Indore Special Economic Zone", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1078-2015", "product_description": "Levalbuterol Inhalation Solution, USP, 0.31 mg/ 3 mL, 3 mL Vials, Rx Only. Manufactured by: Cipla Ltd. Plot 9 & 10, Indure, SEZ, Pithampur, M.P.-454 775, INDIA, Manufactured for: Dr. Reddy's Laboratories, Inc., Princeton NJ 08640.  NDC: 43598-412-25.", "product_quantity": "140,625 Vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.", "recall_initiation_date": "20150424", "center_classification_date": "20150514", "termination_date": "20170214", "report_date": "20150520", "code_info": "Lot #: FA4022; Expiry: December 2015.", "more_code_info": ""}, {"status": "Terminated", "city": "Ciudad Apodaca", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86333", "recalling_firm": "Nanomateriales Sa De Cv", "address_1": "Avenida Milimex 215", "address_2": "Col. Milimex, Apodaca", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CA, NY and Mexico", "recall_number": "D-1593-2020", "product_description": "Zanilast+ Gel Antiseptic Hand Sanitizer (70% Ethyl Alcohol) Packaged in 25 kg bottles,  Distributed by Fujimura Trading S.A. DE C.V. Juventino Rosas 1902, Col. Caracol, 64810, Monterrey, N.L., Mexico Nanomateriales S.A. DE C.V. NDC 69912-006-01", "product_quantity": "1,000 kg", "reason_for_recall": "GMP Deviations: Potential to contain 1-propanol.", "recall_initiation_date": "20200818", "center_classification_date": "20200923", "termination_date": "20240705", "report_date": "20200930", "code_info": "All lots"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070967"], "brand_name": ["SENSORCAINE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-461", "63323-472", "63323-463", "63323-468"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE", "EPINEPHRINE BITARTRATE"], "rxcui": ["1012377", "1012384", "1012413", "1012417", "1724786", "1724787", "1724809", "1724810", "1867594", "1867596", "1867618", "1867620"], "spl_id": ["cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"], "spl_set_id": ["bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"], "package_ndc": ["63323-472-03", "63323-472-17", "63323-472-01", "63323-472-37", "63323-463-01", "63323-463-57", "63323-461-01", "63323-461-57", "63323-468-02", "63323-468-37", "63323-468-01", "63323-468-17"], "is_original_packager": [true], "upc": ["0363323472030", "0363323461010", "0363323463014", "0363323468026", "0363323472016", "0363323468019"], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "91198", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0129-2023", "product_description": "Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 25 mg per 10 mL (2.5 mg per mL), 10 mL Single Dose Vial (NDC 63323-468-01), packaged in 25 Single Dose Vials per tray (NDC 63323-468-17), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.", "product_quantity": "31,600 vials", "reason_for_recall": "Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.", "recall_initiation_date": "20221122", "center_classification_date": "20230113", "termination_date": "20231023", "report_date": "20230125", "code_info": "Batch #: 6128800, exp 12/2023"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MELATONIN Tablet, 3 mg may be potentially mislabeled as    DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD25452_13, EXP: 5/3/2014;  PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD28322_4, EXP: 4/30/2014;  COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD70655_11, EXP: 5/28/2014;  COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree", "address_2": "", "product_quantity": "718 Tablets", "code_info": "MELATONIN, Tablet, 3 mg has the following codes    Pedigree: AD25452_16, EXP: 5/3/2014;  Pedigree: AD28322_7, EXP: 5/6/2014;  Pedigree: AD70655_14, EXP: 5/28/2014;  Pedigree: W003999, EXP: 7/1/2014;  Pedigree: AD32325_7, EXP: 5/9/2014;  Pedigree: AD68019_7, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MELATONIN Tablet, 3 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 51991001406", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-605-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209167"], "brand_name": ["TADALAFIL"], "generic_name": ["TADALAFIL"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-369", "16729-370", "16729-371", "16729-372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TADALAFIL"], "rxcui": ["402019", "403957", "484814", "757707"], "spl_id": ["23a78ce7-48c7-e053-e063-6394a90a743d"], "spl_set_id": ["eedf3ad9-7d40-496d-b1a9-6200010c18e1"], "package_ndc": ["16729-369-10", "16729-369-15", "16729-369-16", "16729-369-17", "16729-369-97", "16729-370-10", "16729-370-15", "16729-370-16", "16729-370-17", "16729-370-97", "16729-371-10", "16729-371-15", "16729-371-16", "16729-371-17", "16729-372-10", "16729-372-15", "16729-372-16", "16729-372-17"], "is_original_packager": [true], "nui": ["N0000175599", "N0000020026"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "unii": ["742SXX0ICT"], "upc": ["316729372107", "316729372169"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0417-2023", "product_description": "Tadalafil Tablets, USP, 20 mg, Rx Only, Packaged as:  a) 30-count bottle NDC 16729-372-10, UPC 3 16729 37210 7; b) 500-count bottle NDC 16729-372-16, UPC 3 16729 37216 9; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA", "product_quantity": "613,553 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2002461, Exp. Date 4/30/2023; P2002457, Exp. Date 4/30/2023; P2002460, Exp. Date 4/30/2023; P2002464, Exp. Date 4/30/2023; P2002463, Exp. Date 4/30/2023; P2002462, Exp. Date 4/30/2023; P2002465, Exp. Date 4/30/2023; P2003153, Exp. Date 5/31/2023; P2003155, Exp. Date 5/31/2023; P2003156, Exp. Date 5/31/2023; P2003154, Exp. Date 5/31/2023; P2003152, Exp. Date 5/31/2023; P2003157, Exp. Date 5/31/2023; P2003158, Exp. Date 5/31/2023; P2003159, Exp. Date 5/31/2023; P2003162, Exp. Date 5/31/2023; P2003160, Exp. Date 5/31/2023; P2003778, Exp. Date 6/30/2023; P2003779, Exp. Date 6/30/2023; P2004315, Exp. Date 6/30/2023; P2004818, Exp. Date 8/31/2023; P2004819, Exp. Date 8/31/2023; P2005158, Exp. Date 8/31/2023; P2005156, Exp. Date 8/31/2023; P2005157, Exp. Date 8/31/2023; P2005247, Exp. Date 9/30/2023; P2006641, Exp. Date 11/30/2023; P2101002, Exp. Date 1/31/2024; P2101004, Exp. Date 1/31/2024; P2101003, Exp. Date 1/31/2024; P2101006, Exp. Date 1/31/2024; P2101005, Exp. Date 1/31/2024; P2101008, Exp. Date 1/31/2024; P2101023, Exp. Date 1/31/2024; P2101022, Exp. Date 1/31/2024; P2101274, Exp. Date 2/29/2024; P2202085, Exp. Date 3/31/2025;   b) P2002467, Exp. Date 4/30/2023; P2002466, Exp. Date 4/30/2023; P2002468, Exp. Date 4/30/2023; P2003780, Exp. Date 6/30/2023; P2005154, Exp. Date 8/31/2023; P2005244, Exp. Date 9/30/2023; P2005246, Exp. Date 9/30/2023; P2005809, Exp. Date 10/31/2023; P2005810, Exp. Date 10/31/2023; P2006642, Exp. Date 11/30/2023; P2006643, Exp. Date 11/30/2023; P2006644, Exp. Date 11/30/2023; P2006645, Exp. Date 11/30/2023; P2006646, Exp. Date 11/30/2023; P2006647, Exp. Date 11/30/2023; P2100463, Exp. Date 12/31/2023; P2100462, Exp. Date 12/31/2023; P2100464, Exp. Date 12/31/2023; P2100465, Exp. Date 12/31/2023; P2100498, Exp. Date 12/31/2023; P2100497, Exp. Date 12/31/2023; P2100499, Exp. Date 12/31/2023; P2100573 ,Exp. Date 1/31/2024; P2100572, Exp. Date 1/31/2024; P2100574, Exp. Date 1/31/2024; P2101007, Exp. Date 1/31/2024; P2202084, Exp. Date 3/31/2025;", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-913-2015", "product_description": "Tamoxifen Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Nixa", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90644", "recalling_firm": "Aire-Master of America Inc", "address_1": "1821 N State Highway Cc", "address_2": "", "postal_code": "65714-8015", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida, Illinois, Iowa, New Jersey", "recall_number": "D-1356-2022", "product_description": "Avant Foaming Hand Sanitizer Ophardt, Fragrance Free, 1000 mL (33.9 fl. oz.) per plastic carton, Manufactured for B4 Brands, Lisbon, Iowa 52253", "product_quantity": "9,176 cartons", "reason_for_recall": "CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.", "recall_initiation_date": "20220715", "center_classification_date": "20220818", "termination_date": "20230219", "report_date": "20220824", "code_info": "Product Number 46076 Lot 722896-exp 07/22, 722996-exp 07/22", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "74746", "recalling_firm": "Clinique International", "address_1": "767 5th Ave", "address_2": "N/A", "postal_code": "10153-0023", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1474-2016", "product_description": "CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-47477-5, Shade 02 (VF-N)", "product_quantity": "1,771,244 bottles for all shades", "reason_for_recall": "Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.", "recall_initiation_date": "20160517", "center_classification_date": "20160826", "termination_date": "20180614", "report_date": "20160907", "code_info": "all lots"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77869", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1123-2017", "product_description": "Rugby  Senexon Liquid Natural Vegetable Stimulant,(Sennosides) 8.8 mg, 8 fl oz (237 mL) plastic bottles, Distributed by: Rugby Laboratories, 17177 N Laurel Park Drive, ?Suite 233, Livonia, MI 48152 --- NDC 0536-1000-59", "product_quantity": "32,413 bottles", "reason_for_recall": "Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination", "recall_initiation_date": "20170802", "center_classification_date": "20170824", "termination_date": "20240716", "report_date": "20170830", "code_info": "Item# 370281 all lots", "more_code_info": ""}, {"country": "United States", "city": "Somerset", "address_1": "265 Davidson Ave Ste 300", "reason_for_recall": "Labeling: Presence of Undeclared Color Additive; The product is being recalled because several inactive ingredients were not included in the labeling for this product: Undeclared D&C Red #33, FD&C Blue #1, Titanium Dioxide Suspension, Purified Water USP.", "address_2": "", "product_quantity": "478,569 Softgel Capsules (172,740 trade plus 305,829 samples).", "code_info": "Lot 249814 Samples  Lot 249816 samples  Lot 260393 exp 4/30/20012  Lot 255345 exp 11/30/2011  Lot 000001 exp 8/31/2012  Lot 261827 exp 5/31/2012  Lot 50004 exp 11/30/2012  Lot 50005 exp 11/30/2012  Lot 500007 exp 12/31/2012  Lot 000002 exp 9/30/20012", "center_classification_date": "20120713", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Prefera OB One Gel Capsules, 30 softgels, Rx Only, Manufactured by: IVC industries, Inc. Irving ton, NJ 07111, For: Alaven Pharmaceutical LLC Marietta, GA 30062, NDC 68220-086-30", "report_date": "20120725", "classification": "Class II", "openfda": {}, "recalling_firm": "Meda Pharmaceuticals Inc.", "recall_number": "D-1418-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61683", "termination_date": "20170208", "more_code_info": "", "recall_initiation_date": "20111017", "postal_code": "08873-4120", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA209196"], "brand_name": ["ADMELOG"], "generic_name": ["INSULIN LISPRO"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "product_ndc": ["0024-5924", "0024-5925", "0024-5926"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["INSULIN LISPRO"], "rxcui": ["242120", "1652639", "1992169", "1992171"], "spl_id": ["9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5"], "spl_set_id": ["0691def8-4a7b-4de3-866f-a280989f47f1"], "package_ndc": ["0024-5924-10", "0024-5925-01", "0024-5925-05", "0024-5925-00", "0024-5926-05"], "is_original_packager": [true], "nui": ["N0000004931", "N0000175453"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["GFX7QIS1II"]}, "product_type": "Drugs", "event_id": "80387", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0925-2018", "product_description": "Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00", "product_quantity": "3214 prefilled pens", "reason_for_recall": "Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.", "recall_initiation_date": "20180705", "center_classification_date": "20180716", "report_date": "20180718", "code_info": "Lot #: 7F021B, Exp 6/30/20", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0949-2019", "product_description": "NET Remedies #20 Pain Relief Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4213-2", "product_quantity": "14249 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: NR-010617M Exp. 01/20; NR-031516C Exp. 03/19; NR-061616L Exp. 06/19; NR-090115F Exp. 09/18; NR-090616M Exp. 09/19; NR-101416L Exp. 10/19; NR-120815C Exp. 12/18; NR-020118P Exp. 02/20; NR-022318K Exp. 02/20; NR-022318M Exp. 02/20; NR-052517A Exp. 05/20; NR-060517F Exp. 06/20; NR-060618A Exp. 06/20; NR-061418A Exp. 06/20; NR-121417B Exp. 12/19"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0206-2015", "product_description": "MITOMYCIN, 0.2mg/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "5 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140913@1, discard date: 10/28/2014"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0391-2020", "product_description": "CVS Health Preservative Free Lubricant Eye Drops (Carboxymethy-Cellulose Sodium 0.5% Glycerin 1% Polysorbate 80 0.5%), Advanced Relief, 30 Sterile Single-Use Containers 0.02 fl. oz. (0.6 mL) each, Item #563442, NDC 50428 30295 8, Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "48,168 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: RJM 10/19   RIA 09/19   SAN 01/20   SFF 06/20"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075356"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0083", "60505-0097", "60505-0084", "60505-0101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["9cde2ef4-fd50-ed21-0628-cb6cd8a6153f"], "spl_set_id": ["08320ea3-8f93-6f04-5d1c-f69af3eb5a81"], "package_ndc": ["60505-0097-1", "60505-0097-9", "60505-0097-2", "60505-0097-4", "60505-0097-7", "60505-0097-5", "60505-0083-1", "60505-0083-9", "60505-0083-2", "60505-0083-4", "60505-0083-0", "60505-0083-5", "60505-0084-1", "60505-0084-9", "60505-0084-2", "60505-0084-4", "60505-0084-5", "60505-0101-1", "60505-0101-9", "60505-0101-2", "60505-0101-4", "60505-0101-5", "60505-0101-7"], "is_original_packager": [true], "upc": ["0360505010110", "0360505008414", "0360505009718", "0360505008315"], "unii": ["3I3T11UD2S"]}, "product_type": "Drugs", "event_id": "93353", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0122-2024", "product_description": "Paroxetine Hydrochloride Tablets USP, RX only, 40 mg, 1000-count bottle, NDC#:60505-0101-4 Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.", "product_quantity": "4,074", "reason_for_recall": "Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine", "recall_initiation_date": "20231101", "center_classification_date": "20231127", "report_date": "20231206", "code_info": "Lot numbers: RV0131, RV2387, RV2389, RW3296, RV2388; Exp. 08/2024", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0898-2022", "product_description": "RE-1 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 200 mcg/mL, packaged as a) 2.5 mL Multi Dose vial, NDC 73198-0015-03; b) 10 mL Multi Dose vial, NDC 73198-0015-10; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835", "product_quantity": "482 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: B24E09-22 BUD: 02/09/2023; B24F09-22 BUD: 02/09/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0093-2016", "product_description": "GLUTATHIONE (L), Injectable Solution, 75 mg/mL, 64 mL syringe , Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "2 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t03192015@31, t04272015@5"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66188", "recalling_firm": "Wellness Pharmacy, Inc.", "address_1": "3401 Independence Drive Suite 231", "address_2": "N/A", "postal_code": "35209-8326", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1033-2013", "product_description": "NA. Phenylbutyrate 200 mg/mL, SDV, a) 10 mL, b) 25 mL, and c) 50 mL, WELLNESS PHARMACY, 1-800-227-2627", "product_quantity": "200 Vials", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.", "recall_initiation_date": "20130823", "center_classification_date": "20130912", "termination_date": "20140603", "report_date": "20130918", "code_info": "Lot# 130621@28, Use by:  10/19/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0947-2020", "product_description": "Coenzyme Q10 Injection,COENZYME Q-10 20MG/ML OIL INJ SOLN, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0411-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 06032019+52353, Exp 7/29/2020; 07082019+52596, Exp 9/2/2020; 10012019+52986, Exp 8/12/2020; 12122019+53374, Exp 1/25/2021"}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0354-2024", "product_description": "Lubricant PM Ointment (Mineral Oil 42.5% and White Petrolatum 57.3%), Packaged in 3.5 gram tubes, Distributed by: AACE Pharmaceuticals, Inc., Fairfield, NJ 07004, NDC 71406-124-35, UPC 371406124356", "product_quantity": "355,120 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #: A2G01, A2G02, Exp. Date Jun-24; A3F08, A3F09, Exp. Date May-25; A3J17, A3J18, Exp. Date Sep-25", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-849-2015", "product_description": "Potassium Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave", "reason_for_recall": "Failed Dissolution Specifications: Unexplained low out of specification results for dissolution.", "address_2": "Suite A", "product_quantity": "3,888 cartons", "code_info": "Lot # 151387, Exp 10/31/16", "center_classification_date": "20160127", "distribution_pattern": "Nationwide and Puerto Rico", "state": "OH", "product_description": "Levofloxacin Tablets USP, 500 mg, packaged in 100-count (10 x 10) blister cards per carton, individual blisters labeled UPC (01) 003 68084 482 11 3, carton labeled NDC 68084-482-01, UPC (01) 0 03 68084 482 01 4; Rx only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217.", "report_date": "20160203", "classification": "Class II", "openfda": {}, "recalling_firm": "Amerisource Health Services", "recall_number": "D-0610-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "73094", "termination_date": "20170111", "recall_initiation_date": "20160118", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89556", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "210 W Main St", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0567-2022", "product_description": "Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDC 67253-903-50), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977", "product_quantity": "70,788 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20220215", "center_classification_date": "20220217", "termination_date": "20221025", "report_date": "20220223", "code_info": "Lot #: a) 19C002A, Exp. Date 03/2022; 19E012A, 19E013A, Exp. Date 05/2022.  b) 19C100B, Exp. Date 04/2022; 19E001B, 19E002B, Exp. Date 05/2022."}, {"status": "Ongoing", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074453"], "brand_name": ["METOPROLOL TARTRATE"], "generic_name": ["METOPROLOL TARTRATE"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "product_ndc": ["69367-354", "69367-355"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL TARTRATE"], "rxcui": ["866511", "866514"], "spl_id": ["dfdf476e-ca66-4836-bc6e-1c8e035d95b0"], "spl_set_id": ["4d352c34-47f8-4662-9ac5-d5a32bd1660f"], "package_ndc": ["69367-354-10", "69367-354-01", "69367-355-10", "69367-355-01"], "is_original_packager": [true], "upc": ["0369367354103"], "unii": ["W5S57Y3A5L"]}, "product_type": "Drugs", "event_id": "97395", "recalling_firm": "Westminster Pharmaceuticals LLC", "address_1": "1321 Murfreesboro Pike Ste 607", "address_2": "N/A", "postal_code": "37217-2693", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0582-2025", "product_description": "Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-355-10", "product_quantity": "4,456 1000-count bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.", "recall_initiation_date": "20250806", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Batch # R56240011, Exp Date: 2/28/26; Batch # R56240021, R56240031, Exp Date: 3/31/26; Batch # R56240041, R56240051, R56240061, Exp Date: 4/30/26; Batch # R56240071, Exp Date: 7/31/26", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1061-2018", "product_description": "Medroxyprogesterone 150 mg/mL 5ml. Rx Only. Packaged in 5 mL vials. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "60 5-ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lots: 58611:42 Use By: 06/07/2018; 59099:42 Use By: 07/24/2018; 58786:42 Use By: 06/24/2018"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206028"], "brand_name": ["MEMANTINE HYDROCHLORIDE"], "generic_name": ["MEMANTINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6734", "0904-6736", "0904-6737", "0904-6735"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MEMANTINE HYDROCHLORIDE"], "rxcui": ["996594", "996603", "996609", "996615"], "spl_id": ["09c5ee21-2a27-45bf-94f7-72e535658b2d"], "spl_set_id": ["f6ce7cca-d245-44f2-986c-2a8d85dbb5fb"], "package_ndc": ["0904-6734-61", "0904-6736-61", "0904-6737-61", "0904-6735-61"], "original_packager_product_ndc": ["68180-246", "68180-247", "68180-248", "68180-249"], "unii": ["JY0WD0UA60"]}, "product_type": "Drugs", "event_id": "85566", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "N/A", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, FL, IA, NY, OH, TX", "recall_number": "D-1262-2020", "product_description": "Memantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, India; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 47152 USA. NDC: 0904-6735-61", "product_quantity": "678 cartons", "reason_for_recall": "Failed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing.", "recall_initiation_date": "20200424", "center_classification_date": "20200513", "termination_date": "20220819", "report_date": "20200520", "code_info": "Lot #: M02199D, M02246D, Exp 5/2020"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091436"], "brand_name": ["LEVOFLOXACIN"], "generic_name": ["LEVOFLOXACIN"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-045", "36000-046", "36000-047", "36000-048"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVOFLOXACIN"], "rxcui": ["1665497", "1665507", "1665515", "1665517"], "spl_id": ["3cbc7b81-fabf-4666-951c-76f19e4f3222"], "spl_set_id": ["70c87464-1806-480a-8ebd-3f02987ff436"], "package_ndc": ["36000-045-01", "36000-046-24", "36000-047-24", "36000-048-24"], "is_original_packager": [true], "upc": ["0336000047241", "0336000045018", "0336000046244"], "nui": ["N0000193223", "M0372253"], "pharm_class_epc": ["Fluoroquinolone Antibacterial [EPC]"], "pharm_class_cs": ["Fluoroquinolones [CS]"], "unii": ["6GNT3Y5LMF"]}, "product_type": "Drugs", "event_id": "80987", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1215-2018", "product_description": "Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24), c) 150 mL (NDC 36000-048-24) Container bags, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India.", "product_quantity": "523,896 bags", "reason_for_recall": "Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.", "recall_initiation_date": "20180925", "center_classification_date": "20180927", "termination_date": "20200626", "report_date": "20181003", "code_info": "Lot #: a) A061178, A061183, A061236, Exp. Date 09/2018; A0A0937, Exp. Date 08/2019; A0A1044, A0A1048, Exp. Date 10/2019.  b) A0A0741, A0A0747, A0A0748, Exp. Date 6/2019; A0A0814, A0A0815, A0A0823, Exp.Date 7/2019; A0A0889, A0A0893, Exp. Date 8/2019; A0A0954, A0A0958, A0A0970, Exp. Date 09/2019; A0A1005, A0A1006, A0A1008, A0A1012, A0A1016, A0A1028, A0A1036, Exp. 10/2019.  c) A061243, Exp. Date 09/2018;  A0A0258, Exp. Date 2/2019; A0A0813, Exp. Date 07/2019; A0A0899, A0A0904, A0A0907, A0A0914, A0A0916, A0A0921, A0A0925, Exp. Date 08/2019; A0A0971, A0A0976, Exp. Date 09/2019; A0A0994, A0A0996, A0A0997, A0A0999, A0A1000, A0A1001, A0A1003, A0A1004, Exp. Date 10/2019", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018801"], "brand_name": ["STERILE WATER"], "generic_name": ["WATER"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4887"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["WATER"], "spl_id": ["900859c0-a075-4fb1-98ce-0e329acc009a"], "spl_set_id": ["2b9ea23a-f9e9-48a8-25b7-519e3bbd6828"], "package_ndc": ["0409-4887-25", "0409-4887-99", "0409-4887-31", "0409-4887-05", "0409-4887-17", "0409-4887-10", "0409-4887-32", "0409-4887-34", "0409-4887-23", "0409-4887-20", "0409-4887-24", "0409-4887-50"], "is_original_packager": [true], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "87831", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0384-2021", "product_description": "Sterile Water for Inj., USP, 25 x 100 mL Single Dose Vials per carton, Rx only, For Drug Diluent Use Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, NDC Carton: 0409-4887-99; NDC Vial: 0409-4887-25", "product_quantity": "49,525 vials", "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as an insect in one vial.", "recall_initiation_date": "20210503", "center_classification_date": "20210514", "termination_date": "20230729", "report_date": "20210526", "code_info": "Lot DN9185"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0322-2019", "product_description": "Amlodipine and Valsartan Tablets, USP 5/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-1723-93.", "product_quantity": "109,314 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers:  3064086, 3066061, 3066062,3073145,3073146,3073147, 3076091, 3077619, 3082432"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; RILUZOLE Tablet, 50 mg may be potentially mislabeled as    traZODone HCl, Tablet, 150 mg, NDC 50111044101, Pedigree: W003245, EXP: 6/17/2014.", "address_2": "", "product_quantity": "240 Tablets", "code_info": "RILUZOLE Tablet, 50 mg has the following code    Pedigree: W003255, EXP: 6/17/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "RILUZOLE Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980019106", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-705-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017512"], "brand_name": ["DIANEAL LOW CALCIUM WITH DEXTROSE"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"], "manufacturer_name": ["Vantive US Healthcare LLC"], "product_ndc": ["0941-0409", "0941-0411", "0941-0413", "0941-0415", "0941-0457", "0941-0459", "0941-0426", "0941-0427", "0941-0429", "0941-0424", "0941-0430", "0941-0433", "0941-0484", "0941-0487", "0941-0490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["799999", "800003", "800057", "800061", "800062", "800064", "800066", "800074", "800111", "800115", "800472", "800474"], "spl_id": ["36ea94f6-f614-9531-e063-6294a90aae55"], "spl_set_id": ["aa268d3f-7389-4f25-801f-5d4825495f08"], "package_ndc": ["0941-0411-05", "0941-0411-06", "0941-0411-07", "0941-0411-04", "0941-0411-11", "0941-0413-05", "0941-0413-06", "0941-0413-07", "0941-0413-01", "0941-0413-04", "0941-0415-05", "0941-0415-06", "0941-0415-04", "0941-0415-07", "0941-0415-01", "0941-0409-06", "0941-0409-05", "0941-0409-07", "0941-0409-01", "0941-0457-08", "0941-0457-02", "0941-0457-05", "0941-0457-01", "0941-0459-08", "0941-0459-02", "0941-0459-05", "0941-0459-01", "0941-0426-52", "0941-0426-53", "0941-0426-55", "0941-0427-52", "0941-0427-53", "0941-0427-55", "0941-0429-52", "0941-0429-53", "0941-0429-55", "0941-0424-51", "0941-0424-52", "0941-0424-53", "0941-0424-55", "0941-0430-51", "0941-0430-52", "0941-0430-53", "0941-0430-55", "0941-0433-51", "0941-0433-52", "0941-0433-53", "0941-0433-55", "0941-0484-01", "0941-0487-01", "0941-0490-01"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "91883", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0542-2023", "product_description": "Dianeal Low Calcium (2.5 mEq/L) Peritonial Dialysis Solution with 1.5% Dextrose, packaged in a) 5000 mL per Ambu-Flex II Container bag, Product Code L5B4826, NDC 0941-0409-07; and b) 6000 mL per Ambu-Flex II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.", "product_quantity": "a) 95,448 bags; b) 174,522 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.", "recall_initiation_date": "20230315", "center_classification_date": "20230424", "report_date": "20230503", "code_info": "Lot #: a) Y406130, Exp 31-Oct-2024; b) Lots Y406314, Y406314A, Y406963, Y407199, Exp 31-Oct-2024"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing", "address_2": "", "product_quantity": "2,978,000/2-caplet packages", "code_info": "Lot# 10118234  Exp 05/13  Lot# 10120254  Exp 05/13   Lot# 10123513  Exp 08/13    Lot#10125262  Exp  09/13", "center_classification_date": "20140116", "distribution_pattern": "Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.", "state": "NE", "product_description": "Excedrin, Sinus Headache, Acetaminophen 325mg,  Phenylephrine HCL 5mg , 2 caplets.  Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02.", "report_date": "20140122", "classification": "Class III", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-744-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65181", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130515", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204453"], "brand_name": ["MINOCYCLINE HYDROCHLORIDE"], "generic_name": ["MINOCYCLINE HYDROCHLORIDE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-436", "67877-578", "67877-576", "67877-577", "67877-643", "67877-644", "67877-437", "67877-438"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MINOCYCLINE HYDROCHLORIDE"], "rxcui": ["629695", "629697", "629699", "858062", "858372", "1013659", "1013662", "1013665"], "spl_id": ["56be27b4-6bdc-4d82-80a9-346e15d61982"], "spl_set_id": ["a8f95207-b259-4f50-87f2-3652d9268890"], "package_ndc": ["67877-578-14", "67877-578-30", "67877-578-01", "67877-578-05", "67877-576-14", "67877-576-30", "67877-576-01", "67877-576-05", "67877-577-14", "67877-577-30", "67877-577-01", "67877-577-05", "67877-643-14", "67877-643-30", "67877-643-01", "67877-643-05", "67877-644-14", "67877-644-30", "67877-644-01", "67877-644-05", "67877-436-14", "67877-436-30", "67877-436-01", "67877-436-05", "67877-437-14", "67877-437-30", "67877-437-01", "67877-437-05", "67877-438-14", "67877-438-30", "67877-438-01", "67877-438-05"], "is_original_packager": [true], "unii": ["0020414E5U"]}, "product_type": "Drugs", "event_id": "84750", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0827-2020", "product_description": "Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054,  NDC 67877-438-30.", "product_quantity": "4728 bottles", "reason_for_recall": "Failed Dissolution Specifications: low out of specification results for dissolution testing.", "recall_initiation_date": "20200122", "center_classification_date": "20200205", "termination_date": "20211027", "report_date": "20200212", "code_info": "Lot #: 19140414, Exp 12/2020"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-124-2014", "product_description": "HCG 250 iu prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "5777 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87981", "recalling_firm": "Miracle 8989", "address_1": "2001 W Northwest Hwy", "address_2": "N/A", "postal_code": "75220-2350", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0634-2021", "product_description": "PremierZEN Platinum 8000 capsule, 1-count blister card (UPC 7 28175 42185 6), packaged in 12 cards per box (UPC 7 28175 42183 2), Distributed by: New Premier Group, Los Angeles, CA  90006", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.", "recall_initiation_date": "20210518", "center_classification_date": "20210622", "termination_date": "20230712", "report_date": "20210630", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["MAXIMUM STRENGTH HYDROCORTISONE CREAM"], "generic_name": ["HYDROCORTISONE CREAM"], "manufacturer_name": ["Walgreens"], "product_ndc": ["0363-0638"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["106258"], "spl_id": ["39dbd277-7e7b-7998-e063-6294a90a1f21"], "spl_set_id": ["2112067c-0fbb-400c-9923-b932946e1a12"], "package_ndc": ["0363-0638-01", "0363-0638-03"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"], "upc": ["311917182452"]}, "product_type": "Drugs", "event_id": "83316", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "N/A", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1733-2019", "product_description": "Hydrocortisone Cream, Hydrocortisone 1% / Anti-Itch Cream, 1 OZ (28 g) tube. Distributed By: Walgreen Co. 200 Wilmot Rd., Deerfield, IL 60015. NDC #0363-0638-03, UPC 3 11917 18245 2         .", "product_quantity": "305 cases", "reason_for_recall": "CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.", "recall_initiation_date": "20190711", "center_classification_date": "20190813", "termination_date": "20200625", "report_date": "20190821", "code_info": "Lot #56J17 EXP 07/2019"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Boric Acid 1% Ear Drop, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0399-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]